Complete Filing Data
Esperion Therapeutics, Inc. reported Net Income Loss of -$22.68 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Esperion Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$22.7M | -$51.7M | -$209.2M | -$233.7M | -$269.1M | -$143.6M | -$97.2M | -$201.8M | -$167.0M | -$75.0M | -$49.8M | -$36.4M | -$26.1M | -$11.7M | -$10.8M |
| Research And Development Expense Excluding Acquired In Process Cost | $47.9M | $46.2M | $86.1M | $118.9M | $106.0M | $146.9M | $175.6M | $171.5M | $147.6M | $57.9M | $29.8M | $25.3M | $16.0M | $8.0M | $7.8M |
| Operating Income Loss | $60.3M | $54.4M | -$155.6M | -$179.5M | -$226.7M | -$121.4M | -$93.1M | -$204.6M | -$169.0M | -$76.2M | -$50.0M | -$36.2M | -$22.8M | -$10.2M | -$10.2M |
| Operating Expenses | $342.9M | $277.9M | $271.9M | $255.0M | $305.2M | $348.9M | $241.5M | $204.6M | $169.0M | $76.2M | $50.0M | $36.2M | $22.8M | $10.2M | $10.2M |
| Other Nonoperating Income Expense | $3.5M | $8.0M | $5.3M | $2.7M | $4.0M | $515.0K | $4.1M | $2.8M | $2.2M | $1.2M | $776.0K | $119.0K | $194.0K | -$84.0K | -$75.8K |
| Interest Expense | $59.0M | $56.8M | $46.4M | $22.7M | $8.1M | $28.0K | $198.0K | $376.0K | $520.0K | $270.0K | $936.0K | $1.5M | $577.2K | ||
| Comprehensive Income Net Of Tax | -$22.7M | -$51.7M | -$209.2M | -$233.6M | -$269.1M | -$143.6M | -$96.8M | -$201.3M | -$167.7M | -$74.7M | -$50.2M | -$36.4M | -$26.1M | -$11.7M | -$10.8M |
| General And Administrative Expense | $65.9M | $33.1M | $21.4M | $18.3M | $20.2M | $10.9M | $6.7M | $2.2M | $2.4M | ||||||
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $0.00 | $0.00 | $2.0K | $29.0K | -$31.0K | -$23.0K | $342.0K | $526.0K | -$673.0K | $310.0K | -$423.0K | -$56.0K | -$3.0K | ||
| Revenue From Contract With Customer Excluding Assessed Tax | $403.1M | $332.3M | $116.3M | $75.5M | $78.4M | $227.5M | $148.4M | $0.00 | |||||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $2.0K | $29.0K | -$31.0K | -$23.0K | $342.0K | $526.0K | -$673.0K | $310.0K | -$423.0K | -$56.0K | -$3.0K | ||||
| Selling General And Administrative Expense | $165.8M | $163.1M | $142.5M | $109.1M | $185.0M | $199.6M | $65.9M | $33.1M | |||||||
| Non Cash Interest Expense Related To Revenue Interest Liability | $0.00 | $21.6M | $46.7M | $44.6M | $33.9M | $19.6M | $8.1M | $0.00 | |||||||
| Payments From Revenue Interest Purchase Agreement | $0.00 | $5.8M | $15.5M | $8.0M | $3.4M | $500.0K | $0.00 | ||||||||
| Revenue Interest Liability Noncurrent | $0.00 | $240.0M | $218.8M | $245.7M | $171.2M | $127.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$31.3M | -$12.7M | -$40.5M | -$29.5M | -$61.9M | $61.0M | -$41.3M | -$49.9M | -$61.7M | -$55.1M | -$66.3M | -$56.7M | -$69.4M | -$43.7M | -$90.9M | -$104.5M | -$85.4M | $124.6M | -$78.2M | -$61.9M | -$68.4M | -$54.2M | $87.4M | -$60.0M | -$49.9M | -$45.7M | -$46.1M | -$37.9M | -$45.2M | -$43.3M | -$40.5M | -$29.0M | -$17.4M | -$14.0M | -$14.6M | -$13.1M | -$12.8M | -$12.4M | -$11.5M | -$9.5M | -$9.8M | -$9.2M | -$7.9M | -$9.7M | -$5.2M | -$6.9M | -$4.2M | -$2.8M | -$3.4M | -$3.2M | -$2.4M |
| Research And Development Expense Excluding Acquired In Process Cost | $14.1M | $7.2M | $12.6M | $10.4M | $11.5M | $13.4M | $14.9M | $22.1M | $31.4M | $29.1M | $32.4M | $24.3M | $25.3M | $25.1M | $28.0M | $42.0M | $35.3M | $35.0M | $34.7M | $38.2M | $48.3M | $42.8M | $46.3M | $49.5M | $41.6M | $39.5M | $40.9M | $33.4M | $40.1M | $38.2M | $35.9M | $24.9M | $13.5M | $9.7M | $9.8M | $8.0M | $7.2M | $7.2M | $7.4M | $6.2M | $7.2M | $6.5M | $5.4M | $7.3M | $3.5M | $3.1M | $2.1M | $1.7M | $2.5M | $2.3M | $1.6M |
| Operating Income Loss | -$10.0M | $7.1M | -$22.1M | -$16.0M | $2.6M | $72.3M | -$27.5M | -$37.1M | -$48.6M | -$41.6M | -$52.4M | -$43.0M | -$55.7M | -$32.5M | -$82.8M | -$95.6M | -$80.6M | $129.2M | -$74.4M | -$59.0M | -$65.8M | -$55.3M | $86.9M | -$60.6M | -$50.6M | -$46.5M | -$46.9M | -$38.7M | -$45.7M | -$43.7M | -$40.9M | -$29.3M | -$17.7M | -$14.3M | -$14.8M | -$13.2M | -$12.9M | -$12.5M | -$11.4M | -$9.4M | -$9.7M | -$9.3M | -$7.9M | -$9.7M | -$5.4M | -$4.3M | -$3.3M | -$2.2M | -$3.0M | -$2.9M | -$2.2M |
| Operating Expenses | $97.3M | $75.3M | $87.1M | $67.7M | $71.3M | $65.5M | $61.5M | $62.8M | $72.9M | $60.6M | $71.2M | $61.8M | $70.2M | $73.2M | $90.8M | $105.2M | $84.4M | $83.1M | $76.3M | $59.9M | $66.7M | $56.3M | $58.5M | $60.6M | $50.6M | $46.5M | $46.9M | $38.7M | $45.7M | $43.7M | $40.9M | $29.3M | $17.7M | $14.3M | $14.8M | $13.2M | $12.9M | $12.5M | $11.4M | $9.4M | $9.7M | $9.3M | $7.9M | $9.7M | $5.4M | $4.3M | $3.3M | $2.2M | $3.0M | $2.9M | $2.2M |
| Other Nonoperating Income Expense | $677.0K | $666.0K | $1.1M | $1.6M | $2.5M | $2.8M | $1.3M | $1.7M | $1.3M | $659.0K | $318.0K | $320.0K | $13.0K | $9.0K | $14.0K | $24.0K | $42.0K | $81.0K | $368.0K | $1.1M | $1.4M | $1.1M | $450.0K | $610.0K | $651.0K | $750.0K | $764.0K | $805.0K | $518.0K | $323.0K | $348.0K | $407.0K | $399.0K | $395.0K | $347.0K | $233.0K | $248.0K | $202.0K | $93.0K | $57.0K | $29.0K | $17.0K | $16.0K | $46.0K | $169.0K | $4.0K | -$25.0K | -$86.0K | $401.00 | $894.00 | $1.1K |
| Interest Expense | $14.0M | $15.0M | $14.5M | $14.4M | $14.2M | $14.3M | $14.1M | $13.7M | $11.1M | $8.1M | $8.9M | $4.9M | $4.6M | $4.2M | $4.1M | $4.0M | $0.00 | $0.00 | $32.0K | $44.0K | $55.0K | $67.0K | $78.0K | $89.0K | $99.0K | $110.0K | $121.0K | $130.0K | $135.0K | $134.0K | $134.0K | $135.0K | $1.0K | $108.0K | $828.0K | $561.7K | $361.4K | $303.2K | $260.4K | ||||||||||||
| Comprehensive Income Net Of Tax | -$31.3M | -$12.7M | -$40.5M | -$29.5M | -$61.9M | $61.0M | -$41.3M | -$49.9M | -$61.7M | -$54.9M | -$66.4M | -$57.0M | -$69.4M | -$43.7M | -$90.9M | -$85.4M | $124.6M | -$78.3M | -$68.4M | -$54.1M | $87.6M | -$49.7M | -$45.5M | -$46.2M | -$45.3M | -$43.3M | -$40.6M | -$17.5M | -$13.9M | -$14.1M | -$12.7M | -$12.4M | -$11.4M | -$9.8M | -$9.2M | -$7.9M | -$5.2M | -$6.9M | -$4.2M | -$3.4M | |||||||||||
| General And Administrative Expense | $21.7M | $18.5M | $13.5M | $12.2M | $11.2M | $9.0M | $7.0M | $6.0M | $5.3M | $5.7M | $5.4M | $5.0M | $4.4M | $4.2M | $4.6M | $5.0M | $5.3M | $5.7M | $5.3M | $4.0M | $3.2M | $2.5M | $2.7M | $2.5M | $2.4M | $1.9M | $1.2M | $1.3M | $505.8K | $533.8K | $533.7K | $632.4K | |||||||||||||||||||
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $0.00 | $0.00 | $0.00 | $0.00 | $1.0K | $1.0K | $204.0K | -$34.0K | -$232.0K | $0.00 | $0.00 | $0.00 | $0.00 | -$9.0K | -$14.0K | $27.0K | $95.0K | $208.0K | $216.0K | $187.0K | -$118.0K | -$112.0K | -$11.0K | -$56.0K | -$96.0K | $103.0K | $497.0K | $71.0K | -$21.0K | $20.0K | $3.0K | -$8.0K | $3.0K | $6.0K | |||||||||||||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $87.3M | $82.4M | $65.0M | $51.6M | $73.8M | $137.7M | $34.0M | $25.8M | $24.3M | $19.0M | $18.8M | $18.8M | $14.4M | $40.7M | $8.0M | $9.6M | $3.8M | $212.2M | $1.8M | $982.0K | $981.0K | $982.0K | $145.4M | ||||||||||||||||||||||||||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $1.0K | $1.0K | $204.0K | -$34.0K | -$232.0K | $0.00 | -$9.0K | -$14.0K | $27.0K | $95.0K | $208.0K | $216.0K | $187.0K | -$118.0K | |||||||||||||||||||||||||||||||||||||
| Selling General And Administrative Expense | $41.8M | $39.5M | $43.0M | $40.0M | $44.2M | $42.0M | $33.2M | $34.0M | $29.9M | $25.0M | $29.6M | $30.4M | $39.3M | $46.3M | $61.1M | $61.6M | $48.8M | $47.7M | $41.6M | $18.5M | $13.5M | $12.2M | |||||||||||||||||||||||||||||
| Non Cash Interest Expense Related To Revenue Interest Liability | $0.00 | $10.9M | $11.3M | $11.0M | $4.9M | $4.2M | |||||||||||||||||||||||||||||||||||||||||||||
| Payments From Revenue Interest Purchase Agreement | $0.00 | $5.8M | $3.1M | $1.2M | $573.0K | $0.00 | |||||||||||||||||||||||||||||||||||||||||||||
| Revenue Interest Liability Noncurrent | $0.00 | $0.00 | $236.4M | $230.4M | $237.0M | $224.9M | $265.0M | $254.0M | $253.4M | $233.5M | $225.8M | $174.6M | $160.2M | $157.0M | $152.7M | $128.4M | $124.4M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$302.0M | -$388.7M | -$455.0M | -$323.8M | -$196.9M | -$96.1M | $20.0M | $79.1M | $244.7M | $228.6M | $287.3M | $133.6M | $74.1M | -$41.4M | -$30.0M | -$19.3M |
| Cash And Cash Equivalents At Carrying Value | $167.9M | $144.8M | $82.2M | $124.8M | $34.5M | $77.3M | $85.0M | $56.5M | $6.5M | $1.6M | $3.4M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $167.9M | $144.8M | $82.2M | $124.8M | $258.9M | $305.0M | $167.1M | $37.0M | $34.5M | $38.2M | $77.3M | |||||
| Property Plant And Equipment Net | $338.0K | $254.0K | $0.00 | $164.0K | $664.0K | $1.3M | $1.1M | $520.0K | $435.0K | $674.0K | $807.0K | $780.0K | $81.0K | $120.2K | ||
| Liabilities Current | $300.8M | $246.2M | $156.2M | $92.3M | $73.4M | $94.1M | $66.1M | $64.3M | $33.1M | $15.6M | $5.6M | $5.5M | $4.2M | $17.2M | ||
| Liabilities And Stockholders Equity | $465.9M | $343.8M | $205.8M | $247.9M | $381.6M | $353.3M | $214.4M | $143.5M | $277.8M | $245.2M | $295.6M | $143.3M | $78.3M | $7.3M | ||
| Liabilities | $767.9M | $732.5M | $660.8M | $571.7M | $578.5M | $449.4M | $194.5M | $64.3M | $33.1M | $16.6M | $8.3M | $9.7M | $4.2M | $24.7M | ||
| Common Stock Value | $245.0K | $196.0K | $118.0K | $75.0K | $61.0K | $26.0K | $27.0K | $27.0K | $26.0K | $23.0K | $23.0K | $20.0K | $15.0K | $346.00 | ||
| Assets Current | $462.6M | $338.0M | $201.1M | $246.7M | $329.0M | $345.9M | $211.7M | $142.6M | $203.9M | $213.6M | $214.4M | $106.7M | $60.6M | $7.1M | ||
| Assets | $465.9M | $343.8M | $205.8M | $247.9M | $381.6M | $353.3M | $214.4M | $143.5M | $277.8M | $245.2M | $295.6M | $143.3M | $78.3M | $7.3M | ||
| Accrued Clinical Development Costs Current | $4.1M | $5.0M | $3.4M | $5.4M | $7.0M | $7.7M | $17.5M | $16.0M | $10.5M | $8.1M | $2.2M | $2.0M | $884.0K | $242.2K | ||
| Accounts Payable Current | $65.1M | $51.7M | $31.7M | $23.0M | $17.6M | $52.0M | $28.9M | $44.9M | $20.4M | $4.6M | $707.0K | $2.0M | $2.2M | $476.3K | ||
| Accretion Amortization Of Discounts And Premiums Investments | $0.00 | $0.00 | $412.0K | -$279.0K | -$12.0K | $97.0K | $200.0K | $217.0K | -$334.0K | -$1.0M | -$647.0K | -$202.0K | -$47.0K | |||
| Retained Earnings Accumulated Deficit | -$1.62B | -$1.60B | -$1.55B | -$1.34B | -$1.11B | -$838.8M | -$695.3M | -$598.1M | -$396.3M | -$229.2M | -$154.2M | -$104.4M | -$68.1M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $0.00 | $0.00 | $0.00 | -$2.0K | -$31.0K | $0.00 | $23.0K | -$319.0K | -$845.0K | -$172.0K | -$482.0K | -$59.0K | -$3.0K | |||
| Prepaid Expense And Other Assets Current | $4.5M | $4.2M | $4.5M | $9.9M | $11.2M | $11.6M | $3.9M | $1.3M | $1.7M | $1.4M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $23.1M | $62.5M | -$42.5M | -$134.1M | -$46.1M | $137.9M | $130.1M | $2.5M | -$3.7M | -$39.2M | ||||||
| Other Accrued Liabilities Current | $25.0M | $13.2M | $30.4M | $24.8M | $11.9M | $3.4M | $1.2M | $1.1M | $1.1M | $835.0K | $1.1M | $210.3K | ||||
| Indefinite Lived Intangible Assets Excluding Goodwill | $56.0K | $56.0K | $56.0K | $56.0K | $56.0K | $56.0K | $56.0K | $56.0K | $53.8K | |||||||
| Non Cash Right Of Use Asset | $37.0K | $98.0K | $115.0K | $5.0K | -$7.0K | $20.0K | $31.0K | $0.00 | ||||||||
| Operating Lease Liability Noncurrent | $653.0K | $2.6M | $3.0M | $665.0K | $524.0K | $3.5M | $1.1M | |||||||||
| Operating Lease Liability Current | $2.1M | $2.7M | $1.6M | $384.0K | $1.4M | $2.6M | $454.0K | |||||||||
| Contract With Customer Liability Current | $34.5M | $8.5M | $25.4M | $3.5M | $5.7M | $1.7M | $2.2M | |||||||||
| Operating Lease Right Of Use Asset | $2.9M | $5.5M | $4.7M | $1.0M | $1.9M | $6.0M | $1.5M | |||||||||
| Inventory Net | $105.1M | $94.5M | $65.6M | $35.2M | $34.4M | $16.1M | $0.00 | |||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Convertible Long Term Notes Payable | $97.3M | $96.7M | $261.6M | $259.9M | $258.3M | $179.4M | $0.00 | |||||||||
| Short Term Investments | $0.00 | $42.1M | $50.4M | $0.00 | $20.8M | $3.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$451.4M | -$433.5M | -$426.2M | -$370.2M | -$344.2M | -$294.3M | -$410.0M | -$372.0M | -$329.7M | -$294.1M | -$291.7M | -$249.0M | -$362.7M | -$304.3M | -$269.4M | $9.0M | $85.5M | -$50.2M | $68.5M | $129.3M | $175.0M | $131.7M | $175.9M | $214.1M | $278.1M | $154.1M | $192.4M | $254.2M | $268.0M | $277.8M | $296.5M | $305.5M | $314.4M | $50.2M | $58.9M | $67.0M | $83.2M | -$52.3M | |||||||||
| Cash And Cash Equivalents At Carrying Value | $92.4M | $86.1M | $114.6M | $144.7M | $189.3M | $226.6M | $114.8M | $138.5M | $144.9M | $159.4M | $122.9M | $150.4M | $208.9M | $103.7M | $219.2M | $217.9M | $305.0M | $215.7M | $298.5M | $149.4M | $166.1M | $212.0M | $274.3M | $174.8M | $37.0M | $26.8M | $24.4M | $30.8M | $21.0M | $20.4M | $19.9M | $38.2M | $47.1M | $48.8M | $37.2M | $80.8M | $129.8M | $208.6M | $40.2M | $47.9M | $48.6M | $71.9M | $16.6M | $3.9M | $3.2M | $2.0M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $92.4M | $86.1M | $114.6M | $144.7M | $189.3M | $226.6M | $114.8M | $138.5M | $144.9M | $209.4M | $172.9M | $200.4M | $153.7M | $219.2M | $217.9M | $215.7M | $298.5M | $150.3M | $212.9M | $275.3M | $176.0M | $26.8M | $24.4M | $30.8M | $21.0M | ||||||||||||||||||||||
| Property Plant And Equipment Net | $175.0K | $201.0K | $228.0K | $281.0K | $307.0K | $268.0K | $6.0K | $32.0K | $83.0K | $256.0K | $361.0K | $511.0K | $817.0K | $970.0K | $1.1M | $1.4M | $1.5M | $1.4M | $958.0K | $903.0K | $439.0K | $583.0K | $311.0K | $374.0K | $497.0K | $558.0K | $623.0K | $622.0K | $685.0K | $743.0K | $722.0K | $680.0K | $728.0K | $840.0K | $851.0K | $360.0K | $78.7K | $89.3K | |||||||||
| Liabilities Current | $359.0M | $298.8M | $271.0M | $165.9M | $175.3M | $164.5M | $137.7M | $107.2M | $95.5M | $82.3M | $82.3M | $79.1M | $78.5M | $82.6M | $97.9M | $75.9M | $83.9M | $73.5M | $57.5M | $54.3M | $60.0M | $42.3M | $35.0M | $30.0M | $35.0M | $31.0M | $21.6M | $8.2M | $7.6M | $6.0M | $6.8M | $7.0M | $6.9M | $5.6M | $5.5M | $3.2M | $3.3M | $6.6M | |||||||||
| Liabilities And Stockholders Equity | $364.0M | $347.1M | $324.0M | $314.1M | $352.3M | $373.1M | $221.3M | $234.6M | $251.8M | $312.8M | $304.0M | $342.9M | $225.3M | $280.5M | $278.6M | $251.0M | $330.4M | $179.6M | $255.3M | $308.8M | $236.5M | $174.0M | $210.9M | $244.2M | $313.1M | $185.2M | $214.6M | $263.8M | $277.5M | $286.0M | $306.4M | $316.0M | $325.2M | $60.5M | $69.3M | $70.2M | $86.6M | $19.5M | |||||||||
| Liabilities | $815.4M | $780.6M | $750.2M | $684.3M | $696.5M | $667.4M | $631.3M | $606.6M | $581.5M | $606.9M | $595.7M | $591.9M | $588.0M | $584.8M | $548.0M | $242.0M | $244.9M | $229.9M | $186.8M | $179.5M | $61.5M | $42.3M | $35.0M | $30.0M | $35.0M | $31.1M | $22.2M | $9.6M | $9.5M | $8.3M | $9.9M | $10.5M | $10.8M | $10.3M | $10.4M | $3.2M | $3.3M | $6.6M | |||||||||
| Common Stock Value | $205.0K | $200.0K | $197.0K | $195.0K | $195.0K | $188.0K | $112.0K | $101.0K | $87.0K | $72.0K | $65.0K | $61.0K | $27.0K | $26.0K | $26.0K | $28.0K | $28.0K | $28.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $26.0K | $23.0K | $23.0K | $23.0K | $23.0K | $23.0K | $23.0K | $22.0K | $22.0K | $15.0K | $15.0K | $15.0K | $15.4K | $396.00 | |||||||||
| Assets Current | $360.5M | $342.6M | $318.8M | $307.6M | $345.1M | $365.6M | $218.2M | $232.1M | $250.6M | $261.8M | $252.5M | $290.8M | $170.7M | $275.2M | $272.6M | $242.8M | $321.4M | $172.6M | $253.5M | $307.1M | $235.2M | $168.2M | $188.9M | $201.4M | $206.8M | $170.9M | $188.0M | $213.5M | $209.1M | $197.1M | $218.8M | $225.7M | $279.8M | $54.6M | $61.3M | $58.3M | $73.0M | $19.4M | |||||||||
| Assets | $364.0M | $347.1M | $324.0M | $314.1M | $352.3M | $373.1M | $221.3M | $234.6M | $251.8M | $312.8M | $304.0M | $342.9M | $225.3M | $280.5M | $278.6M | $251.0M | $330.4M | $179.6M | $255.3M | $308.8M | $236.5M | $174.0M | $210.9M | $244.2M | $313.1M | $185.2M | $214.6M | $263.8M | $277.5M | $286.0M | $306.4M | $316.0M | $325.2M | $60.5M | $69.3M | $70.2M | $86.6M | $19.5M | |||||||||
| Accrued Clinical Development Costs Current | $1.6M | $1.2M | $7.1M | $3.5M | $3.4M | $3.0M | $3.5M | $5.6M | $4.6M | $4.0M | $11.4M | $3.7M | $3.7M | $2.9M | $7.5M | $21.7M | $19.6M | $22.7M | $21.0M | $17.3M | $18.9M | $20.0M | $9.5M | $15.4M | $11.0M | $8.3M | $6.4M | $2.4M | $2.5M | $1.4M | $963.0K | $1.0M | $2.0M | $929.0K | $360.0K | $526.0K | $450.0K | $923.8K | |||||||||
| Accounts Payable Current | $77.5M | $74.7M | $72.0M | $34.9M | $47.7M | $28.4M | $26.2M | $24.6M | $17.1M | $18.6M | $12.8M | $26.8M | $20.7M | $29.4M | $30.3M | $17.6M | $29.7M | $15.1M | $23.7M | $28.4M | $33.3M | $18.6M | $22.5M | $12.0M | $19.5M | $18.7M | $11.6M | $1.8M | $1.6M | $1.5M | $2.0M | $3.3M | $2.9M | $3.3M | $4.2M | $2.1M | $1.9M | $1.7M | |||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $0.00 | $339.0K | -$173.0K | $0.00 | $73.0K | $75.0K | -$148.0K | -$254.0K | -$27.0K | -$53.0K | |||||||||||||||||||||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$1.69B | -$1.65B | -$1.64B | -$1.58B | -$1.55B | -$1.49B | -$1.49B | -$1.45B | -$1.40B | -$1.28B | -$1.23B | -$1.16B | -$1.04B | -$971.9M | -$928.2M | -$734.3M | -$648.9M | -$773.5M | -$633.3M | -$564.9M | -$510.7M | -$538.1M | -$488.2M | -$442.4M | -$358.4M | -$313.2M | -$269.8M | -$200.2M | -$182.8M | -$168.8M | -$141.1M | -$128.3M | -$115.9M | -$95.0M | -$85.2M | ||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $0.00 | $0.00 | $0.00 | $0.00 | -$1.0K | -$93.0K | -$297.0K | -$263.0K | $0.00 | $9.0K | $11.0K | -$16.0K | -$111.0K | -$560.0K | -$776.0K | -$963.0K | -$351.0K | -$239.0K | -$228.0K | $22.0K | $118.0K | $15.0K | $11.0K | -$60.0K | -$39.0K | $2.0K | $5.0K | $3.0K | $6.0K | ||||||||||||||||||
| Prepaid Expense And Other Assets Current | $4.4M | $5.4M | $4.8M | $14.4M | $10.6M | $11.3M | $6.3M | $4.3M | $5.6M | $9.2M | $9.2M | $10.8M | $10.3M | $9.8M | $34.2M | $16.9M | $11.5M | $11.4M | $2.8M | $792.0K | $923.0K | $1.6M | $1.1M | $1.3M | $1.8M | $986.0K | $1.3M | ||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$30.1M | $144.4M | $20.1M | -$58.5M | -$87.0M | -$16.7M | $139.1M | -$3.6M | |||||||||||||||||||||||||||||||||||||||
| Other Accrued Liabilities Current | $9.9M | $4.8M | $3.8M | $3.6M | $2.8M | $2.0M | $3.0M | $2.3M | $1.9M | $2.2M | $1.9M | $1.4M | $2.3M | $1.3M | $1.1M | $1.2M | $885.0K | $564.0K | $948.4K | $1.2M | |||||||||||||||||||||||||||
| Indefinite Lived Intangible Assets Excluding Goodwill | $56.0K | $56.0K | $56.0K | $56.0K | $56.0K | $56.0K | $56.0K | $56.0K | $56.0K | $56.0K | $56.0K | $56.0K | $56.0K | $56.0K | $56.0K | $56.0K | $56.0K | $56.0K | $56.0K | $55.7K | $55.7K | ||||||||||||||||||||||||||
| Non Cash Right Of Use Asset | $30.0K | $72.0K | $1.0K | $6.0K | $4.0K | $91.0K | $25.0K | ||||||||||||||||||||||||||||||||||||||||
| Operating Lease Liability Noncurrent | $767.0K | $1.3M | $2.0M | $3.3M | $4.0M | $4.4M | $2.0M | $1.7M | $782.0K | $47.0K | $135.0K | $263.0K | $1.3M | $1.9M | $2.5M | $4.1M | $4.0M | $3.7M | $820.0K | $759.0K | $792.0K | ||||||||||||||||||||||||||
| Operating Lease Liability Current | $2.4M | $2.7M | $2.8M | $2.7M | $2.7M | $2.5M | $918.0K | $687.0K | $305.0K | $693.0K | $957.0K | $1.2M | $2.4M | $2.3M | $2.3M | $2.6M | $2.2M | $1.9M | $267.0K | $199.0K | $184.0K | ||||||||||||||||||||||||||
| Contract With Customer Liability Current | $30.7M | $22.3M | $4.5M | $15.1M | $20.7M | $29.4M | $19.7M | $15.6M | $12.2M | $4.0M | $5.0M | $3.8M | $3.1M | $3.9M | $2.5M | $1.7M | $1.1M | $1.2M | $2.6M | $3.6M | $3.9M | ||||||||||||||||||||||||||
| Operating Lease Right Of Use Asset | $3.3M | $4.2M | $5.0M | $6.2M | $6.8M | $7.1M | $3.0M | $2.4M | $1.1M | $730.0K | $1.1M | $1.5M | $3.7M | $4.3M | $4.9M | $6.7M | $6.2M | $5.5M | |||||||||||||||||||||||||||||
| Inventory Net | $108.5M | $114.5M | $99.3M | $80.1M | $84.5M | $73.1M | $51.4M | $45.7M | $39.4M | $29.5M | $29.2M | $35.7M | $34.0M | $23.7M | $20.0M | $9.1M | $8.2M | $1.8M | |||||||||||||||||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||||
| Convertible Long Term Notes Payable | $97.1M | $97.0M | $96.9M | $262.9M | $262.5M | $262.0M | $261.2M | $260.7M | $260.3M | $259.5M | $259.1M | $258.7M | $272.5M | $272.1M | $271.7M | ||||||||||||||||||||||||||||||||
| Short Term Investments | $0.00 | $0.00 | $17.4M | $29.9M | $62.9M | $68.1M | $163.0M | $158.4M | $157.3M | $134.9M | $134.8M | $95.0M | $69.5M | $12.7M | $11.8M | $8.1M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $36.2M | $86.5M | $50.5M | $32.6M | $268.2M | $201.7M | $136.2M | $10.7M | $163.5M | -$1.6M | $190.5M | $97.1M | $89.1M | $15.8M | $6.7M |
| Investing Cash Flow * | $0.00 | -$317.0K | $42.5M | $8.1M | -$50.5M | $21.4M | $64.2M | $140.4M | -$35.9M | $10.1M | -$160.1M | -$36.6M | -$21.0M | -$2.0K | $509.0K |
| Operating Cash Flow * | -$13.1M | -$23.7M | -$135.5M | -$174.8M | -$263.8M | -$85.2M | -$70.3M | -$148.6M | -$131.3M | -$47.7M | -$38.2M | -$32.0M | -$18.1M | -$10.8M | -$9.1M |
| Share Based Compensation | $9.9M | $12.0M | $12.0M | $15.2M | $24.3M | $28.4M | $25.9M | $24.0M | $18.6M | $16.0M | $12.7M | $3.7M | $1.2M | $80.0K | $78.5K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $30.8M | $13.9M | -$6.2M | -$1.4M | -$99.0K | $2.4M | $3.4M | $2.9M | $1.7M | -$139.0K | $1.3M | $264.0K | -$27.0K | $429.0K | -$168.3K |
| Increase Decrease In Other Accrued Liabilities | $31.2M | $18.3M | $22.1M | $4.0M | $6.9M | $2.8M | $10.0M | $7.6M | $2.5M | $6.0M | $519.0K | $814.0K | $1.4M | -$195.0K | $14.4K |
| Increase Decrease In Accounts Payable | $20.9M | $12.4M | $8.7M | $5.6M | $23.1M | -$16.1M | $24.4M | $15.8M | $3.9M | -$1.3M | -$299.0K | $1.8M | -$215.0K | $619.2K | |
| Proceeds From Stock Options Exercised | $0.00 | $3.8M | $6.6M | $11.8M | $11.7M | $1.2M | $45.0K | $1.2M | $473.0K | $123.0K | $41.0K | $15.9K | |||
| Payments To Acquire Property Plant And Equipment | $0.00 | $317.0K | $0.00 | $0.00 | $0.00 | $869.0K | $953.0K | $151.0K | $19.0K | $94.0K | $325.0K | $873.0K | $31.0K | $7.0K | $33.6K |
| Payments To Acquire Investments | $0.00 | $0.00 | $59.9M | $50.5M | $4.4M | $34.3M | $25.5M | $219.6M | $197.2M | $280.6M | $48.1M | $24.7M | |||
| Proceeds From Sale And Maturity Of Available For Sale Securities | $0.00 | $0.00 | $42.5M | $68.0M | $0.00 | $39.1M | $99.5M | $166.1M | $183.7M | $207.4M | $120.8M | $12.4M | |||
| Proceeds From Issuance Of Common Stock | $513.0K | $4.4M | $90.8M | $9.7M | $0.00 | $0.00 | $164.0M | $190.0M | $91.7M | $72.2M | |||||
| Increase Decrease In Contract With Customer Liability | $26.0M | -$16.9M | $21.9M | -$2.8M | $4.7M | -$490.0K | $2.2M | $0.00 | |||||||
| Increase Decrease In Inventories | $10.6M | $28.9M | $30.4M | $807.0K | $18.3M | $16.1M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | -$7.5M | $90.6M | $49.5M | -$1.4M | $2.0M | $26.0M | $1.7M | $9.3M | -$150.0K | -$364.0K | $190.4M | $52.0K | |
| Investing Cash Flow * | $0.00 | -$73.0K | $25.0M | -$18.1M | $0.00 | $26.6M | $45.7M | $30.3M | $16.2M | -$30.0M | -$57.5M | $1.2M | $1.0K |
| Operating Cash Flow * | -$22.6M | $53.8M | -$54.4M | -$39.0M | -$89.1M | -$69.3M | $91.7M | -$43.2M | -$34.3M | -$9.8M | -$9.3M | -$9.1M | -$2.6M |
| Share Based Compensation | $2.5M | $3.2M | $2.9M | $4.4M | $5.8M | $7.1M | $6.6M | $5.9M | $4.2M | $4.6M | $2.1M | $741.0K | $55.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $4.9M | $6.6M | $1.6M | -$764.0K | $4.9M | $2.5M | -$1.3M | $421.0K | $4.1M | $451.0K | $860.0K | $1.0M | $656.0K |
| Increase Decrease In Other Accrued Liabilities | -$932.0K | -$2.1M | -$1.2M | -$3.0M | $25.0M | $16.7M | $3.4M | $5.8M | -$1.0M | -$487.0K | $76.0K | -$866.0K | $834.0K |
| Increase Decrease In Accounts Payable | $27.8M | -$3.5M | -$6.0M | $9.4M | -$21.6M | -$13.7M | -$11.5M | -$8.4M | $7.0M | $833.0K | $813.0K | -$159.0K | $450.0K |
| Proceeds From Stock Options Exercised | $0.00 | $2.7M | $1.0M | $1.7M | $9.7M | $267.0K | $27.0K | $264.0K | $52.0K | ||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $73.0K | $0.00 | $0.00 | $191.0K | $189.0K | $14.0K | $7.0K | $273.0K | ||||
| Payments To Acquire Investments | $0.00 | $18.1M | $0.00 | $4.4M | $14.6M | $28.2M | $70.3M | $70.4M | $3.0M | ||||
| Proceeds From Sale And Maturity Of Available For Sale Securities | $0.00 | $25.0M | $0.00 | $0.00 | $31.2M | $45.9M | $44.9M | $44.4M | $40.3M | ||||
| Proceeds From Issuance Of Common Stock | $0.00 | $90.7M | $0.00 | $0.00 | $190.2M | ||||||||
| Increase Decrease In Contract With Customer Liability | -$4.0M | $3.9M | $8.7M | -$2.1M | $881.0K | -$982.0K | $4.6M | ||||||
| Increase Decrease In Inventories | $4.8M | $7.5M | $4.2M | $1.3M | $3.9M | $1.8M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.11 | -$0.28 | -$2.03 | -$3.52 | -$9.31 | -$5.23 | -$3.59 | -$7.54 | -$6.98 | -$3.33 | -$2.26 | -$2.22 | -$3.31 | -$36.31 | -$36.22 | ||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 27.5M | 27.1M | 26.8M | 23.9M | 22.5M | 22.0M | 16.4M | 7.9M | 323.4K | 298.7K | |||||||
| Common Stock Shares Authorized | 480.0M | 480.0M | 480.0M | 240.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 50.0M | 50.0M | 45.0M | 44.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Issued | 247.2M | 197.8M | 120.2M | 76.6M | 62.9M | 27.9M | 27.5M | 26.8M | 26.3M | 22.6M | 22.5M | 20.4M | 15.4M | 346.5K | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 0.00 | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Shares Outstanding Basic | 207.9M | 187.2M | 103.1M | 66.4M | 28.9M | 27.5M | 27.1M | ||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 207.9M | 187.2M | 103.1M | 66.4M | 28.9M | 27.5M | 27.1M | ||||||||||
| Earnings Per Share Basic | $-0.11 | $-0.28 | $-2.03 | $-3.52 | $-9.31 | $-5.23 | $-3.59 | ||||||||||
| Common Stock Shares Outstanding | 27.5M | 26.8M | 26.3M | 22.6M | 22.5M | 20.3M | 15.3M | 346.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.16 | -$0.06 | -$0.21 | -$0.15 | -$0.33 | $0.34 | -$0.37 | -$0.46 | -$0.79 | -$0.81 | -$1.05 | -$0.93 | -$2.62 | -$1.67 | -$3.50 | -$3.07 | $4.32 | -$2.84 | -$2.52 | -$2.01 | $3.07 | -$2.24 | -$1.86 | -$1.71 | -$1.73 | -$1.44 | -$1.86 | -$1.92 | -$1.80 | -$1.29 | -$0.77 | -$0.62 | -$0.65 | -$0.58 | -$0.57 | -$0.55 | -$0.56 | -$0.49 | -$0.64 | -$0.60 | -$0.51 | -$0.63 | -$0.34 | -$19.82 | -$12.24 | -$8.12 | -$10.31 | -$9.94 | -$7.96 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 26.0M | 27.8M | 27.5M | 27.2M | 26.8M | 26.8M | 26.8M | 26.6M | 26.2M | 24.3M | 22.6M | 22.6M | 22.6M | 22.6M | 22.5M | 22.5M | 22.5M | 22.5M | 22.5M | 20.6M | 19.3M | 15.4M | 15.4M | 15.4M | 15.3M | 15.3M | 349.2K | 346.5K | 341.9K | 325.0K | 318.7K | 307.7K | |||||||||||||||||
| Common Stock Shares Authorized | 480.0M | 480.0M | 480.0M | 480.0M | 480.0M | 480.0M | 480.0M | 480.0M | 240.0M | 240.0M | 240.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | |||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||
| Common Stock Shares Issued | 207.4M | 202.1M | 198.7M | 197.4M | 196.6M | 189.8M | 114.1M | 102.9M | 89.2M | 73.7M | 66.6M | 63.1M | 28.8M | 28.3M | 28.2M | 27.9M | 27.8M | 27.5M | 27.2M | 27.0M | 26.9M | 26.8M | 26.8M | 26.8M | 26.2M | 22.6M | 22.6M | 22.6M | 22.5M | 22.5M | 22.5M | 22.5M | 22.5M | 15.5M | 15.4M | 15.4M | 15.4M | ||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | ||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 200.7M | 197.5M | 196.1M | 194.9M | 188.8M | 169.3M | 111.9M | 109.2M | 78.4M | 67.8M | 63.2M | 61.0M | 26.5M | 26.2M | 26.0M | 27.8M | 27.7M | 27.5M | 27.0M | 26.8M | 26.8M | 26.6M | |||||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 200.7M | 197.5M | 196.1M | 194.9M | 188.8M | 189.6M | 111.9M | 109.2M | 78.4M | 67.8M | 63.2M | 61.0M | 26.5M | 26.2M | 26.0M | 27.8M | 28.9M | 27.5M | 27.0M | 28.4M | 26.8M | 26.6M | |||||||||||||||||||||||||||
| Earnings Per Share Basic | $-0.16 | $-0.06 | $-0.21 | $-0.15 | $-0.33 | $0.36 | $-0.37 | $-0.46 | $-0.79 | $-0.81 | $-1.05 | $-0.93 | $-2.62 | $-1.67 | $-3.50 | $-3.07 | $4.50 | $-2.84 | $-2.01 | $3.26 | $-1.71 | $-1.73 | |||||||||||||||||||||||||||
| Common Stock Shares Outstanding | 27.9M | 27.8M | 27.5M | 27.2M | 27.0M | 26.9M | 26.8M | 26.8M | 26.8M | 26.2M | 22.6M | 22.6M | 22.6M | 22.5M | 22.5M | 22.5M | 22.5M | 22.4M | 15.4M | 15.4M | 15.4M | 15.3M | 372.1K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $9.9M | $12.0M | $12.0M | $15.2M | $24.3M | $28.4M | $25.9M | $24.0M | $18.6M | $16.0M | $12.7M | $3.7M | $1.2M | $80.0K | $78.5K |
| Depreciation | $105.0K | $63.0K | $164.0K | $500.0K | $612.0K | $547.0K | $319.0K | $265.0K | $258.0K | $252.0K | $236.0K | $160.0K | $71.0K | $139.0K | $178.5K |
| Prepaid Clinical Development Costs Current | $4.0M | $586.0K | $193.0K | $1.0M | $1.1M | $844.0K | $6.1M | $5.3M | $2.1M | $560.0K | $888.0K | $366.0K | $196.0K | $367.2K | |
| Additional Paid In Capital | $1.38B | $1.27B | $1.15B | $1.07B | $964.4M | $797.7M | $715.2M | $677.5M | $641.8M | $458.0M | $441.9M | $238.0M | $142.1M | $610.0K | |
| Stock Issued During Period Value Stock Options Exercised | $244.0K | $29.0K | $3.8M | $6.6M | $11.8M | $11.7M | $1.2M | $45.0K | $1.2M | $473.0K | $28.0K | $41.0K | $15.9K | ||
| Other Cost And Expense Operating | $68.6M | $43.3M | $27.0M | $14.2M | $2.4M | $0.00 | $0.00 | ||||||||
| Amortization Of Financing Costs | $12.0K | $23.0K | $32.0K | $16.0K | $19.0K | $15.0K | |||||||||
| Stock Issued During Period Value Restricted Stock Award Gross | $2.0K | $2.0K | $1.0K | $1.0K | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Stock Issued During Period Value New Issues | $72.6M | $90.7M | $4.4M | $90.8M | $9.7M | $164.0M | $190.0M | $91.6M | $72.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.3M | $2.7M | $2.5M | $3.0M | $2.9M | $3.2M | $3.0M | $3.2M | $2.9M | $3.5M | $3.5M | $4.4M | $5.5M | $8.6M | $5.8M | $7.3M | $7.4M | $7.1M | $6.3M | $6.6M | $6.6M | $5.5M | $5.7M | $5.9M | ||||||||||||||||
| Depreciation | $26.0K | $0.00 | $81.0K | $153.0K | $153.0K | $106.0K | $71.0K | $61.0K | $69.0K | $64.0K | $59.0K | $12.0K | $32.0K | |||||||||||||||||||||||||||
| Prepaid Clinical Development Costs Current | $2.8M | $4.2M | $504.0K | $499.0K | $349.0K | $0.00 | $3.0M | $2.9M | $6.9M | $2.2M | $373.0K | $698.0K | $986.0K | $650.0K | $443.0K | $1.1M | $890.0K | $1.2M | $5.7M | $4.0M | $4.4M | $7.4M | $7.7M | $2.9M | $1.6M | $2.6M | $4.8M | $1.7M | $1.1M | $1.4M | $2.0M | $550.0K | $1.1M | $894.0K | $1.3M | $1.3M | $503.4K | $212.6K | ||
| Additional Paid In Capital | $1.29B | $1.28B | $1.27B | $1.26B | $1.26B | $1.25B | $1.14B | $1.13B | $1.13B | $1.05B | $993.0M | $969.3M | $733.5M | $722.5M | $713.8M | $743.3M | $734.4M | $723.2M | $701.8M | $694.3M | $685.8M | $670.3M | $664.8M | $657.5M | $636.8M | $467.5M | $462.5M | $454.4M | $450.7M | $446.5M | $437.5M | $433.8M | $430.3M | $145.2M | $144.1M | $143.0M | $141.6M | $796.5K | ||
| Stock Issued During Period Value Stock Options Exercised | $141.0K | $29.0K | $375.0K | $168.0K | $2.7M | $1.6M | $3.7M | $1.0M | $1.2M | $1.9M | $1.7M | $28.0K | $1.6M | $9.8M | ||||||||||||||||||||||||||
| Other Cost And Expense Operating | $41.3M | $28.5M | $31.5M | $17.3M | $15.6M | $10.1M | $13.4M | $6.8M | $11.7M | $6.5M | $9.2M | $7.1M | $5.6M | $1.8M | $1.8M | $1.7M | $275.0K | $398.0K | $31.0K | $0.00 | ||||||||||||||||||||
| Amortization Of Financing Costs | $437.0K | $417.0K | $398.0K | $400.0K | $0.00 | $4.0K | $7.0K | $8.0K | $19.0K | |||||||||||||||||||||||||||||||
| Stock Issued During Period Value Restricted Stock Award Gross | $1.0K | $0.00 | $1.0K | $1.0K | $1.0K | $1.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||
| Stock Issued During Period Value New Issues | $10.5M | $2.8M | $513.0K | $90.7M | $4.4M | $52.4M | $48.7M | $20.2M | $4.2M |
Most recent annual filing with the SEC: March 10, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.